Veterinary raw materials
Human APIs Powder
- Respiratory Drugs Raw Material
- Antiviral Antibacterial
- Antipyretic Analgesics
- Antihistamine Drugs
- Antineoplastic
- Cosmetic Raw Material
Pharmaceutical
OEM & ODM
Phone: 86-29-89601602
E-mail: sales21@interlgroup.com
Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
Raw material intermediate Danofloxacin mesylate Powder
Product Overview:
Darifloxacin mesylate has strong antibacterial effects mainly against Gram-positive bacteria (G+), certain anaerobes and mycoplasmas. It is sensitive to Streptococcus aureus, Streptococcus haemolyticus, Pneumococcus, Legionella pneumophila, Mycoplasma, and also sensitive to Clostridium difficile, Clostridium weissei, Tetanus bacillus, and Mycobacterium avium.
Raw material intermediate Danofloxacin mesylate Powder Attributes
CAS:119478-55-6
MF:C20H24FN3O6S
MW:453.48
EINECS:638-813-3
Specification: 99% min Danofloxacin mesylate Powder
Sample: Danofloxacin mesylate Powder
Packaging:1kg/bag, 25kg/drum
Brand: Henrikang
Appearance: White to Off-White
Storage: Cool Dry Place
Shelf Life: 2 Years
Test Method: HPLC
Raw material intermediate Danofloxacin mesylate Powder Details
Danofloxacin mesylate Powder Usage and Synthesis.
Darifloxacin mesylate has strong antibacterial effects mainly against Gram-positive bacteria (G+), certain anaerobes and mycoplasmas. It is sensitive to Streptococcus aureus, Streptococcus haemolyticus, Pneumococcus, Legionella pneumophila, Mycoplasma, and also sensitive to Clostridium difficile, Clostridium weissei, Tetanus bacillus, and Mycobacterium avium.
Uses of Danofloxacin mesylate.
For infections of livestock (G+) bacteria, certain anaerobes, mycoplasma and spirochetes.
1. lung infections caused by a mixture of Staphylococcus aureus, Streptococcus haemolyticus, Pneumococcus, Legionella pneumophila.
2. avian chronic respiratory disease caused by Mycoplasma, porcine asthma.
3. proliferative enteritis, spirochete dysentery, toxoplasmosis in pigs; 4. necrotising enteritis in chickens.
4. necrotising enteritis in chickens; 5. actinomycosis in pets.
5. pet actinomycosis.
Pharmacological Effects of Danofloxacin mesylate.
Darifloxacin mesylate has strong antibacterial effects mainly against Gram-positive bacteria (G+), certain anaerobes and mycoplasmas. It is sensitive to Streptococcus aureus, Streptococcus haemolyticus, Pneumococcus, Legionella pneumophila, Mycoplasma, and also sensitive to Clostridium difficile, Clostridium weissei, Tetanus bacillus, and Mycobacterium avium.
Dafloxacin mesylate is clinically used for infections caused by epimycin-resistant and erythromycin-resistant bacteria; mycoplasma infections caused by avian chronic respiratory disease and porcine asthma; necrotising enteritis in chickens; porcine dense spirochete dysentery, toxoplasmosis; pet actinomycosis.
In vitro studies of Danofloxacin mesylate.
Danofloxacin is a synthetic antimicrobial agent of the fluoroquinolone class that acts primarily through inhibition of bacterial DNA-promoter enzymes, which are necessary for DNA super-helixation to provide proper spatial arrangement of DNA in the bacterial cell.The minimum inhibitory concentration (MIC) of Danofloxacin, resistant to 90 per cent (MIC90) contemporary European and North American regional Pasteurellahaemolytica, Pasteurellamultocida and Haemophilussomnus, the most important respiratory pathogens of livestock, was 0.125 µg/ml